These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22948743)

  • 1. The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.
    Linhares UC; Schiavoni PB; Barros PO; Kasahara TM; Teixeira B; Ferreira TB; Alvarenga R; Hygino J; Vieira MM; Bittencourt VC; Andrade RM; Andrade AF; Bento CA
    J Clin Immunol; 2013 Jan; 33(1):179-89. PubMed ID: 22948743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
    Barros PO; Cassano T; Hygino J; Ferreira TB; Centurião N; Kasahara TM; Andrade RM; Linhares UC; Andrade AF; Vasconcelos CC; Alvarenga R; Marignier R; Bento CA
    Clin Exp Immunol; 2016 Mar; 183(3):480-9. PubMed ID: 26472479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels.
    Barros PO; Linhares UC; Teixeira B; Kasahara TM; Ferreira TB; Alvarenga R; Hygino J; Silva-Filho RG; Bittencourt VC; Andrade RM; Andrade AF; Bento CA
    Hum Immunol; 2013 Sep; 74(9):1080-7. PubMed ID: 23777933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
    Jarius S; Wildemann B
    J Neurol Sci; 2015 Nov; 358(1-2):419-21. PubMed ID: 26303625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
    Xu W; Li R; Dai Y; Wu A; Wang H; Cheng C; Qiu W; Lu Z; Zhong X; Shu Y; Kermode AG; Hu X
    J Neuroimmunol; 2013 Aug; 261(1-2):87-91. PubMed ID: 23726764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cells in neuromyelitis optica spectrum disorder: a review.
    Lin J; Li X; Xia J
    Int J Neurosci; 2016 Dec; 126(12):1051-60. PubMed ID: 26954363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica.
    Matsuya N; Komori M; Nomura K; Nakane S; Fukudome T; Goto H; Shiraishi H; Wandinger KP; Matsuo H; Kondo T
    Int Immunol; 2011 Sep; 23(9):565-73. PubMed ID: 21795759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Devic's neuromyelitis optica and related neurological disorders].
    Marignier R; Confavreux C
    Presse Med; 2010 Mar; 39(3):371-80. PubMed ID: 20116202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
    Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Devic's index case: A critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
    Jarius S; Wildemann B
    J Neurol Sci; 2019 Dec; 407():116396. PubMed ID: 31726278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
    Drori T; Chapman J
    Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
    Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
    J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenesis of neuromyelitis optica.
    Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
    Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
    Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
    Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
    Weinshenker BG; Wingerchuk DM
    Curr Top Microbiol Immunol; 2008; 318():343-56. PubMed ID: 18219825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for neuromyelitis optica.
    Chang KH; Ro LS; Lyu RK; Chen CM
    Clin Chim Acta; 2015 Feb; 440():64-71. PubMed ID: 25444748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.